These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 20185622)

  • 1. Northern light: a commentary on the 2009 Canadian Guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in adults.
    Schaefer EJ
    Clin Chem; 2010 Apr; 56(4):502-4. PubMed ID: 20185622
    [No Abstract]   [Full Text] [Related]  

  • 2. 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations.
    Genest J; McPherson R; Frohlich J; Anderson T; Campbell N; Carpentier A; Couture P; Dufour R; Fodor G; Francis GA; Grover S; Gupta M; Hegele RA; Lau DC; Leiter L; Lewis GF; Lonn E; Mancini GB; Ng D; Pearson GJ; Sniderman A; Stone JA; Ur E
    Can J Cardiol; 2009 Oct; 25(10):567-79. PubMed ID: 19812802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The new dyslipidemia guidelines: what is the debate?
    Anderson TJ; Mancini GB; Genest J; Grégoire J; Lonn EM; Hegele RA
    Can J Cardiol; 2015 May; 31(5):605-12. PubMed ID: 25816728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical practice guidelines for the management of dyslipidemia in chronic kidney disease].
    Shoji T
    Nihon Jinzo Gakkai Shi; 2013; 55(7):1267-75. PubMed ID: 24288962
    [No Abstract]   [Full Text] [Related]  

  • 5. [Are therapeutic LDL goals justified? Controversies between the European and American guidelines].
    Bertomeu-Martínez V
    Medwave; 2016 Dec; 16(Suppl4):e6825. PubMed ID: 28055995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid Disorders: Screening and Treatment.
    Jin J
    JAMA; 2016 Nov; 316(19):2056. PubMed ID: 27838718
    [No Abstract]   [Full Text] [Related]  

  • 7. [Guidelines-oriented diagnostics of dyslipidemia].
    Kaiser T; Thiery J
    Herz; 2012 Nov; 37(7):773-82. PubMed ID: 23052898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult.
    Anderson TJ; Grégoire J; Hegele RA; Couture P; Mancini GB; McPherson R; Francis GA; Poirier P; Lau DC; Grover S; Genest J; Carpentier AC; Dufour R; Gupta M; Ward R; Leiter LA; Lonn E; Ng DS; Pearson GJ; Yates GM; Stone JA; Ur E
    Can J Cardiol; 2013 Feb; 29(2):151-67. PubMed ID: 23351925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simplifying the approach to the management of dyslipidemia.
    Gaziano JM; Gaziano TA
    JAMA; 2009 Nov; 302(19):2148-9. PubMed ID: 19920241
    [No Abstract]   [Full Text] [Related]  

  • 10. Universal screening and drug treatment of dyslipidemia in children and adolescents.
    Psaty BM; Rivara FP
    JAMA; 2012 Jan; 307(3):257-8. PubMed ID: 22174386
    [No Abstract]   [Full Text] [Related]  

  • 11. [Position of Interdisciplinary Spanish Committee for Cardiovascular Prevention about dyslipemia treatment guidelines].
    Millán Núñez-Cortés J; Lahera Juliá V; Vázquez Carrera M; Pedro-Botet J
    Clin Investig Arterioscler; 2015; 27(1):34-5. PubMed ID: 25556158
    [No Abstract]   [Full Text] [Related]  

  • 12. Re: Canadian Cardiovascular Society position statement--recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease.
    MacNair K; Bugden S;
    Can J Cardiol; 2007 May; 23(6):481-2; author reply 483. PubMed ID: 17549843
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparing Guidelines for Statin Treatment in Canada and the United States.
    Hennessy DA; Bushnik T; Manuel DG; Anderson TJ
    J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26175357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of inherited atherogenic dyslipidemias in children.
    Guardamagna O; Cagliero P; Abello F
    Ther Apher Dial; 2013 Apr; 17(2):150-61. PubMed ID: 23551671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New european guidelines for dyslipidemia].
    Riesen WF; Virgini V; Vogt B; Rodondi N
    Rev Med Suisse; 2012 Mar; 8(331):525-6, 528-30. PubMed ID: 22471115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [To improve cardiovascular health: we are forced for not loosing impulse].
    Millán Núñez-Cortés J; Mantilla Morató T; Lobos Bejarano JM; Pedro-Botet Montoya J
    Clin Investig Arterioscler; 2016; 28(1):43-6. PubMed ID: 26589871
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational study.
    Halcox JP; Banegas JR; Roy C; Dallongeville J; De Backer G; Guallar E; Perk J; Hajage D; Henriksson KM; Borghi C
    BMC Cardiovasc Disord; 2017 Jun; 17(1):160. PubMed ID: 28623902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dyslipidemias and statins: from guidelines to clinical practice. An updated review of the literature].
    Lucchi T; Vergani C
    G Ital Cardiol (Rome); 2014 Mar; 15(3):149-60. PubMed ID: 24770428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of dyslipidemia in 2014: European versus American guidelines].
    Radermecker RP
    Rev Med Suisse; 2014 Aug; 10(439):1534-7. PubMed ID: 25272669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time to improve statin prescription guidelines in low-risk patients?
    Balder JW; de Vries JK; Mulder DJ; Kamphuisen PW
    Eur J Prev Cardiol; 2017 Jul; 24(10):1064-1070. PubMed ID: 28429651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.